CAS 941685-27-4: 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl-7H-pyrrolo[2,3-d]pyrimidine

Fórmula: C₁₅H₂₁N₅OSi

4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine

CAS: 941685-27-4

• Fórmula: C₁₅H₂₁N₅OSi
• Pureza: %
• Cor e Forma: Solid
• Peso molecular: 315.4456

Ruxolitinib Impurity 4

CAS: 941685-27-4

• Fórmula: C₁₅H₂₁N₅OSi
• Cor e Forma: Off-White Solid
• Peso molecular: 315.45

4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine

CAS: 941685-27-4

• Pureza: 95%
• Peso molecular: 315.45g/mol

INCB032304

CAS: 941685-27-4

INCB032304: Key for making Ruxolitinib, a JAK inhibitor, and Barretinib.

• Fórmula: C₁₅H₂₁N₅OSi
• Pureza: 100% - 99.26%
• Cor e Forma: Solid
• Peso molecular: 315.45

4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)-METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE

CAS: 941685-27-4

• Pureza: 95.0%
• Cor e Forma: Solid
• Peso molecular: 315.4519958496094

4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine

CAS: 941685-27-4

Applications 4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine is an important intermediate in the preparation of the janus kinase inhibitor INCB018424. …

• Fórmula: C₁₅H₂₁N₅OSi
• Cor e Forma: Neat
• Peso molecular: 315.446

4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine

CAS: 941685-27-4

4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine is a synthetic compound that can be used to discriminate between the left and …

• Fórmula: C₁₅H₂₁N₅OSi
• Pureza: Min. 95%
• Peso molecular: 315.45 g/mol